Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 1Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 4

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Dermatologic 4

Conditions

Melanoma 4Skin Neoplasms 3Margins of Excision 2Dysplastic Nevus Syndrome 2Disease 2Carcinoma, Basal Cell 2Recurrence 1Non-melanoma Skin Cancer 1Nevus, Pigmented 1Nevus 1Carcinoma, Squamous Cell 1

Interventions

pembrolizumab 300Nivolumab 273Ipilimumab 250aldesleukin 137Cyclophosphamide 136Interleukin-2 105trametinib 82dabrafenib 76Temozolomide 75Dacarbazine 74Vemurafenib 71fludarabine 68fludarabine phosphate 62Biopsy 49binimetinib 47sargramostim 44Radiosurgery 44Bevacizumab 43Paclitaxel 42encorafenib 40incomplete Freund's adjuvant 39atezolizumab 38Radiotherapy 37Specimen Handling 36Cisplatin 36CTLA-4 Antigen 36Magnetic Resonance Spectroscopy 35Carboplatin 35cobimetinib 34Introns 33

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Melanoma × Dermoscopy × Clear all
NCT03699995 2026-04-08

MoleMapper, Visiomed, and Confocal Microscopy in Screening Participants for Melanoma

OHSU Knight Cancer Institute

Phase NA Terminated
17 enrolled
Dermatologic

Melanoma, Nevus, Pigmented

NCT05446155 2024-01-23

BioMEL

Region Skane

Recruiting
2,000 enrolled
Dermatologic

Dysplastic Nevus Syndrome, Melanoma, Nevus, Skin Neoplasms

NCT04789421 2021-03-09

NET-DAM

Azienda Ospedaliero-Universitaria di Modena

Phase NA Completed
3,248 enrolled
Dermatologic

Disease, Melanoma

NCT03362138 2018-09-13

NNCD

Assuta Hospital Systems

Unknown
80 enrolled
Dermatologic

Disease, Dysplastic Nevus Syndrome, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡